FATE OF PARTIALLY PURIFIED C14-LABELED TOXIN OF CLOSTRIDIUM PERFRINGENS
AUTOR(ES)
Ellner, Paul D.
RESUMO
Ellner, Paul D. (University of Florida, Gainesville). Fate of partially purified C14-labeled toxin of Clostridium perfringens. J. Bacteriol. 82:275–283. 1961.—A study was made of the fate of Clostridium perfringens toxin in susceptible animals. Labeled toxin was prepared by growing C. perfringens type A in a complex casein hydrolyzate medium containing a tryptic hydrolyzate of C14-labeled algal protein. The toxin was purified about 30-fold (in terms of lecithinase activity) by ammonium sulfate and acetone precipitations. The tagged toxin was injected intravenously into mice and rabbits, and the disappearance from the blood stream, deposition in organs and appearance in urine and expired air determined by measurement of radioactivity. Experimental data showed that toxin disappears rapidly from the bloodstream following intravenous injection, with radioactivity appearing in the urine and expired air shortly thereafter (10 to 20 min). The organs primarily responsible for the uptake of toxin from the blood are the liver (72%), lungs (15%), kidney (8%), and spleen (5%). The toxin is not bound to skeletal muscle. Fractionation of the liver into subcellular particles by centrifugation showed the radioactivity to be concentrated in the mitochondrial fraction. These experiments indicate that the toxin is rapidly removed from the circulating blood, is metabolized, and breakdown products excreted in the urine, with 1 carbon fragments eliminated as CO2 in the expired air.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=279155Documentos Relacionados
- FERMENTATION OF C14-LABELED GLUCOSE BY CLOSTRIDIUM PERFRINGENS1
- METABOLISM OF PENTOSES BY CLOSTRIDIA II. Clostridium perfringens, Clostridium beijerinckii, andClostridium butylicum: The Fermentation of C14-Labeled Pentoses by1
- INCORPORATION OF C14-LABELED SUBSTRATES INTO VIOLACEIN1
- DISSIMILATION OF C14-LABELED GLUCOSE BY SERRATIA MARCESCENS
- DETERMINATION OF HUMAN PLATELET SURVIVAL UTILIZING C14-LABELED SEROTONIN*